StockClub

EYPT

EYPTEyePoint Pharmaceuticals, Inc.$ --
EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

EYPT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
1M USD
YoY -94.6%
Operating Income
-70M USD
YoY -55.5%
Net Income
-68M USD
YoY -63.3%
EPS
-0.81$
YoY -26.6%

Revenue

$31.4M
FY2024 Q1$11.7M
$11.7M
Q1
FY2024 Q2$21.2M
$21.2M
Q2
FY2024 Q3$31.7M
$31.7M
Q3
FY2024 Q4$43.3M
$43.3M
Q4
FY2025 Q1$24.5M
$24.5M
Q1
FY2025 Q2$29.8M
$29.8M
Q2
FY2025 Q3$30.8M
$30.8M
Q3
FY2025 Q4$31.4M
$31.4M
Q4
Actual
$-11.9M (-27.5%)

Net Income

$-232M
FY2024 Q1$-29.3M
$-29.3M
Q1
FY2024 Q2$-60.1M
$-60.1M
Q2
FY2024 Q3$-89.5M
$-89.5M
Q3
FY2024 Q4$-130.9M
$-130.9M
Q4
FY2025 Q1$-45.2M
$-45.2M
Q1
FY2025 Q2$-104.6M
$-104.6M
Q2
FY2025 Q3$-164.4M
$-164.4M
Q3
FY2025 Q4$-232M
$-232M
Q4
Actual
$-101.1M (-77.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$34.4M
Est:$45.6M
FY2020MISS
$34.4M
FY2021BEAT
Actual:$36.9M
Est:$35.2M
FY2021BEAT
$36.9M
FY2022BEAT
Actual:$41.4M
Est:$41.3M
FY2022BEAT
$41.4M
FY2023MISS
Actual:$46M
Est:$50.4M
FY2023MISS
$46M
FY2024BEAT
Actual:$43.3M
Est:$42.5M
FY2024BEAT
$43.3M
FY2025MISS
Actual:$31.4M
Est:$31.8M
FY2025MISS
$31.4M

Analyst Estimates